CHLORAMBUCIL

CHLORAMBUCIL was reported 3932 times

CHLORAMBUCIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT LYMPHOMA UNCLASSIFIABLE HIGH GRADE 2 0.4000
1 T-CELL LYMPHOMA STAGE IV 18 0.3158
2 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III 5 0.2778
3 TYROSINE KINASE MUTATION 4 0.1600
4 MICROSPORIDIA INFECTION 48 0.1368
5 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV 6 0.1333
6 GENOTOXICITY 5 0.1316
7 LYMPHADENITIS VIRAL 4 0.1000
8 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY 9 0.0957
9 CITROBACTER SEPSIS 3 0.0750
10 BLOOD STEM CELL TRANSPLANT FAILURE 16 0.0744
11 NATURAL KILLER-CELL LYMPHOBLASTIC LYMPHOMA 3 0.0732
12 UVEAL MELANOMA 4 0.0714
13 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE IV 2 0.0714
14 BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED 2 0.0571
15 MALIGNANT TRANSFORMATION 25 0.0557
16 ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ASSOCIATED POLYNEUROPATHY 2 0.0541
17 BING-NEEL SYNDROME 2 0.0513
18 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 33 0.0473
19 CAPNOCYTOPHAGA INFECTION 4 0.0426
20 TP53 GENE MUTATION 4 0.0412
21 SECONDARY IMMUNODEFICIENCY 50 0.0412
22 CEREBRAL ASPERGILLOSIS 25 0.0407
23 FUNGAL ABSCESS CENTRAL NERVOUS SYSTEM 3 0.0395
24 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 9 0.0391
25 LEUKAEMIA CUTIS 6 0.0390
26 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION 8 0.0383
27 MENINGORADICULITIS 4 0.0370
28 HYPERFIBRINOLYSIS 2 0.0364
29 CAMPYLOBACTER INFECTION 28 0.0337
30 GEOTRICHUM INFECTION 7 0.0332
31 RETINITIS VIRAL 4 0.0331
32 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 10 0.0330
33 PROSTATIC ABSCESS 9 0.0326
34 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 20 0.0305
35 LISTERIA SEPSIS 8 0.0303
36 ACUTE MYELOMONOCYTIC LEUKAEMIA 7 0.0278
37 COOMBS INDIRECT TEST POSITIVE 2 0.0270
38 HYPOGLOBULINAEMIA 3 0.0265
39 BONE MARROW LEUKAEMIC CELL INFILTRATION 2 0.0244
40 HAEMOPHILUS TEST POSITIVE 3 0.0233
41 UPPER RESPIRATORY TRACT INFECTION BACTERIAL 5 0.0233
42 CD19 LYMPHOCYTES DECREASED 3 0.0231
43 BACILLARY ANGIOMATOSIS 3 0.0221
44 REFRACTORY ANAEMIA 4 0.0217
45 CELL-MEDIATED IMMUNE DEFICIENCY 3 0.0214
46 POLYMYOSITIS 36 0.0203
47 APOPTOSIS 6 0.0194
48 CHRONIC HEPATITIS B 6 0.0189
49 NEUTROPENIC INFECTION 18 0.0188
50 AUTOIMMUNE THROMBOCYTOPENIA 8 0.0185
51 HEPATITIS B SURFACE ANTIGEN POSITIVE 5 0.0182
52 FACIAL DYSMORPHISM 4 0.0181
53 RHODOCOCCUS INFECTION 3 0.0181
54 BLOOD IMMUNOGLOBULIN G ABNORMAL 3 0.0180
55 CHRONIC LYMPHOCYTIC LEUKAEMIA 85 0.0179
56 VIRAL LOAD 3 0.0173
57 CREUTZFELDT-JAKOB DISEASE 5 0.0173
58 AUTOIMMUNE NEUTROPENIA 5 0.0173
59 GREATER TROCHANTERIC PAIN SYNDROME 3 0.0146
60 ANGIOCENTRIC LYMPHOMA 7 0.0142
61 PROCALCITONIN INCREASED 16 0.0136
62 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 111 0.0134
63 ANAEMIA HAEMOLYTIC AUTOIMMUNE 11 0.0133
64 JC VIRUS INFECTION 21 0.0131
65 CRYOGLOBULINAEMIA 9 0.0126
66 PHARYNGITIS BACTERIAL 3 0.0116
67 KLEBSIELLA URINARY TRACT INFECTION 3 0.0113
68 COOMBS TEST POSITIVE 3 0.0110
69 PALPABLE PURPURA 3 0.0109
70 CEREBELLAR ISCHAEMIA 2 0.0108
71 ANAEMIA OF MALIGNANT DISEASE 3 0.0107
72 CEREBRAL TOXOPLASMOSIS 10 0.0107
73 HIGH-GRADE B-CELL LYMPHOMA 2 0.0107
74 WOLFF-PARKINSON-WHITE SYNDROME 5 0.0106
75 MYOSITIS 91 0.0101
76 HYPOGAMMAGLOBULINAEMIA 66 0.0100
77 ENCEPHALITIS VIRAL 12 0.0099
78 MYCOBACTERIUM CHELONAE INFECTION 7 0.0095
79 CENTRAL NERVOUS SYSTEM LYMPHOMA 13 0.0094
80 SECOND PRIMARY MALIGNANCY 75 0.0090
81 ENTEROCOLITIS INFECTIOUS 8 0.0087
82 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 5 0.0085
83 ACUTE MYELOID LEUKAEMIA 131 0.0084
84 HERPES ZOSTER MENINGOENCEPHALITIS 3 0.0083
85 PANNICULITIS 20 0.0083
86 BLINDNESS CORTICAL 4 0.0082
87 ENTEROBACTER SEPSIS 3 0.0081
88 HUMORAL IMMUNE DEFECT 3 0.0081
89 ERYTHEMA INFECTIOSUM 2 0.0078
90 NEUTROPENIC SEPSIS 55 0.0077
91 GASTROINTESTINAL LYMPHOMA 2 0.0077
92 BETA 2 MICROGLOBULIN INCREASED 2 0.0077
93 MOLLUSCUM CONTAGIOSUM 4 0.0074
94 B-CELL LYMPHOMA RECURRENT 4 0.0074
95 MYELODYSPLASTIC SYNDROME 100 0.0069
96 NON-HODGKIN'S LYMPHOMA 9 0.0069
97 FOLLICULAR LYMPHOMA 6 0.0068
98 TUMOUR LYSIS SYNDROME 60 0.0068
99 HYPERLEUKOCYTOSIS 6 0.0068
100 SPLENIC RUPTURE 11 0.0067
101 CATARACT SUBCAPSULAR 4 0.0066
102 ADENOCARCINOMA OF COLON 12 0.0064
103 CEREBELLAR ATAXIA 6 0.0063
104 PNEUMOCOCCAL SEPSIS 4 0.0061
105 APRAXIA 9 0.0061
106 ACUTE HEPATITIS B 2 0.0060
107 METASTATIC SQUAMOUS CELL CARCINOMA 3 0.0059
108 GIARDIASIS 2 0.0059
109 PNEUMOCYSTIS JIROVECII INFECTION 7 0.0059
110 DEAFNESS TRANSITORY 5 0.0059
111 DIFFUSE LARGE B-CELL LYMPHOMA 42 0.0054
112 PULMONARY MYCOSIS 4 0.0051
113 CHRONIC HEPATITIS C 2 0.0051
114 VASCULAR PURPURA 7 0.0050
115 ENTEROCOCCAL INFECTION 24 0.0050
116 BLOOD IMMUNOGLOBULIN M INCREASED 3 0.0049
117 LYMPHOCYTIC LEUKAEMIA 2 0.0049
118 LOW SET EARS 2 0.0049
119 ENDOMETRIAL ADENOCARCINOMA 3 0.0047
120 NECROTISING RETINITIS 3 0.0047
121 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 3 0.0047
122 BLOOD IMMUNOGLOBULIN A DECREASED 3 0.0046
123 PNEUMONIA STREPTOCOCCAL 5 0.0046
124 TRANSFUSION REACTION 4 0.0046
125 SEQUESTRECTOMY 3 0.0045
126 BIOPSY BONE MARROW ABNORMAL 2 0.0044
127 AUTOIMMUNE HAEMOLYTIC ANAEMIA 15 0.0044
128 T-CELL LYMPHOMA 5 0.0044
129 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 2 0.0044
130 ADENOCARCINOMA GASTRIC 4 0.0043
131 PSEUDOMONAS INFECTION 36 0.0042
132 BONE DEBRIDEMENT 2 0.0041
133 LYMPHOPENIA 58 0.0041
134 INTRAOCULAR LENS IMPLANT 2 0.0040
135 SERUM SICKNESS 11 0.0039
136 INTERVERTEBRAL DISC COMPRESSION 4 0.0038
137 ENDOCARDITIS BACTERIAL 3 0.0038
138 CYTOPENIA 46 0.0038
139 HEPATITIS VIRAL 3 0.0037
140 JC VIRUS TEST POSITIVE 3 0.0036
141 TONIC CONVULSION 5 0.0035
142 EMPYEMA 7 0.0035
143 LEGIONELLA INFECTION 2 0.0035
144 APLASIA PURE RED CELL 12 0.0035
145 AORTIC CALCIFICATION 2 0.0034
146 HYPERSENSITIVITY VASCULITIS 9 0.0034
147 HISTIOCYTOSIS HAEMATOPHAGIC 10 0.0034
148 BRONCHOPULMONARY ASPERGILLOSIS 26 0.0034
149 ANTEROGRADE AMNESIA 2 0.0033
150 CATARRH 3 0.0033
151 SQUAMOUS CELL CARCINOMA 31 0.0033
152 BILIARY TRACT INFECTION 2 0.0032
153 BRONCHOPNEUMONIA 11 0.0032
154 CORNEAL PERFORATION 2 0.0032
155 GLOMERULOSCLEROSIS 2 0.0032
156 BONE MARROW DEPRESSION 3 0.0031
157 ASPERGILLUS INFECTION 20 0.0030
158 CHRONIC MYELOMONOCYTIC LEUKAEMIA 2 0.0030
159 CONJUNCTIVAL OEDEMA 3 0.0029
160 CACHEXIA 15 0.0029
161 VARICELLA ZOSTER VIRUS INFECTION 6 0.0029
162 DERMATITIS EXFOLIATIVE GENERALISED 10 0.0029
163 PSEUDOMONAL SEPSIS 5 0.0029
164 LYMPHOCYTOSIS 6 0.0028
165 PNEUMONIA FUNGAL 11 0.0028
166 BRAIN ABSCESS 7 0.0028
167 MEAN CELL VOLUME INCREASED 7 0.0027
168 EPSTEIN-BARR VIRUS INFECTION 17 0.0027
169 GASTROINTESTINAL TOXICITY 13 0.0027
170 MANTLE CELL LYMPHOMA 4 0.0026
171 DEVICE RELATED INFECTION 40 0.0026
172 EPIDIDYMITIS 3 0.0026
173 SYSTEMIC MYCOSIS 3 0.0026
174 BRONCHIAL CARCINOMA 2 0.0025
175 GENE MUTATION 5 0.0025
176 INTERVERTEBRAL DISC SPACE NARROWING 2 0.0025
177 SKIN TOXICITY 14 0.0025
178 LYMPHOCYTE COUNT INCREASED 8 0.0024
179 FEBRILE NEUTROPENIA 162 0.0024
180 HYPERURICAEMIA 10 0.0024
181 BLOOD IMMUNOGLOBULIN G DECREASED 6 0.0024
182 NEUTROPENIC COLITIS 5 0.0024
183 LEUKAEMIA RECURRENT 4 0.0024
184 RESPIRATORY TRACT INFECTION 61 0.0023
185 PULMONARY TUBERCULOSIS 10 0.0023
186 ATYPICAL PNEUMONIA 7 0.0023
187 SQUAMOUS CELL CARCINOMA OF SKIN 14 0.0023
188 SPLENIC INFARCTION 4 0.0023
189 CEREBELLAR ATROPHY 2 0.0023
190 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 5 0.0023
191 PSEUDOMEMBRANOUS COLITIS 5 0.0022
192 HYPERPLASIA 2 0.0022
193 HEPATITIS B REACTIVATION 7 0.0022
194 B-LYMPHOCYTE COUNT DECREASED 3 0.0022
195 EXTENSOR PLANTAR RESPONSE 2 0.0022
196 CHOLECYSTITIS INFECTIVE 6 0.0022
197 BACTERIAL SEPSIS 7 0.0021
198 LEUKOENCEPHALOPATHY 8 0.0021
199 H1N1 INFLUENZA 3 0.0021
200 COR PULMONALE 2 0.0021
201 ACTINOMYCOSIS 2 0.0021
202 BLOOD LACTATE DEHYDROGENASE INCREASED 33 0.0021
203 ESCHERICHIA SEPSIS 6 0.0021
204 BONE SWELLING 2 0.0021
205 LUNG INFECTION 32 0.0021
206 SKIN FRAGILITY 5 0.0021
207 NEUTROPENIA 279 0.0020
208 SPLENOMEGALY 24 0.0020
209 CYTOMEGALOVIRUS INFECTION 34 0.0020
210 HAEMOPHILUS INFECTION 2 0.0020
211 HEMIANOPIA 2 0.0020
212 INFLAMMATORY MARKER INCREASED 10 0.0020
213 STEM CELL TRANSPLANT 5 0.0020
214 BONE MARROW DISORDER 6 0.0020
215 CARDIAC DISCOMFORT 4 0.0020
216 CAPILLARY LEAK SYNDROME 4 0.0019
217 NEOPLASM SKIN 3 0.0019
218 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
219 BLOOD DISORDER 15 0.0019
220 PNEUMONIA BACTERIAL 17 0.0019
221 OPTIC ATROPHY 3 0.0018
222 CRYPTOCOCCOSIS 3 0.0018
223 HAEMORRHAGIC DISORDER 2 0.0018
224 ARRHYTHMIA SUPRAVENTRICULAR 2 0.0018
225 ACINETOBACTER INFECTION 2 0.0018
226 CEREBELLAR SYNDROME 4 0.0018
227 HEPATITIS B 11 0.0018
228 EPSTEIN-BARR VIRAEMIA 2 0.0018
229 THROMBOCYTOPENIA 199 0.0018
230 CLOSTRIDIAL INFECTION 6 0.0018
231 SPLEEN DISORDER 3 0.0018
232 ACUTE LYMPHOCYTIC LEUKAEMIA 5 0.0018
233 GLIOBLASTOMA 3 0.0018
234 BLADDER NEOPLASM 3 0.0018
235 INFECTION REACTIVATION 2 0.0017
236 IMMUNE THROMBOCYTOPENIA 8 0.0017
237 NEUROLOGICAL DECOMPENSATION 4 0.0017
238 LYMPHADENOPATHY 60 0.0017
239 HAEMOLYSIS 13 0.0017
240 HAEMOLYTIC ANAEMIA 15 0.0017
241 ESCHERICHIA TEST POSITIVE 2 0.0017
242 DYSPLASIA 2 0.0017
243 LUNG ADENOCARCINOMA 5 0.0017
244 DISORGANISED SPEECH 3 0.0016
245 GENERAL PHYSICAL CONDITION ABNORMAL 11 0.0016
246 VITRITIS 3 0.0016
247 INTRA-ABDOMINAL HAEMATOMA 2 0.0016
248 PNEUMOCYSTIS JIROVECII PNEUMONIA 16 0.0016
249 CUTANEOUS T-CELL LYMPHOMA 2 0.0016
250 HUMAN HERPESVIRUS 6 INFECTION 3 0.0016
251 LUNG INFILTRATION 14 0.0016
252 BONE MARROW FAILURE 32 0.0016
253 AORTIC ARTERIOSCLEROSIS 4 0.0016
254 INFUSION RELATED REACTION 102 0.0015
255 ASPERGILLOSIS 2 0.0015
256 BICYTOPENIA 3 0.0015
257 OTITIS MEDIA 5 0.0015
258 HIRSUTISM 2 0.0015
259 MUCOSAL DRYNESS 3 0.0015
260 B-CELL LYMPHOMA 5 0.0015
261 OSTEOLYSIS 3 0.0015
262 SUDDEN CARDIAC DEATH 5 0.0015
263 ORAL FUNGAL INFECTION 4 0.0015
264 ULCERATIVE KERATITIS 4 0.0015
265 IMMUNOGLOBULINS DECREASED 2 0.0015
266 INTRACRANIAL PRESSURE INCREASED 8 0.0014
267 ECHOCARDIOGRAM ABNORMAL 2 0.0014
268 DILATATION VENTRICULAR 3 0.0014
269 SKIN INFECTION 16 0.0014
270 ALVEOLITIS 2 0.0014
271 CONNECTIVE TISSUE DISORDER 2 0.0014
272 BLADDER TRANSITIONAL CELL CARCINOMA 2 0.0014
273 HERPES SIMPLEX 9 0.0014
274 PANCYTOPENIA 77 0.0014
275 ENDOCARDITIS 7 0.0014
276 COCCYDYNIA 2 0.0014
277 DISEASE PROGRESSION 156 0.0013
278 MARASMUS 2 0.0013
279 LICHENOID KERATOSIS 3 0.0013
280 BLOOD PRESSURE IMMEASURABLE 2 0.0013
281 ENCEPHALITIS 9 0.0013
282 CHRONIC MYELOID LEUKAEMIA 6 0.0013
283 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
284 ESCHERICHIA BACTERAEMIA 3 0.0013
285 HYPERKERATOSIS 7 0.0013
286 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0013
287 RETINAL HAEMORRHAGE 9 0.0013
288 LIMB DEFORMITY 2 0.0013
289 STREPTOCOCCAL INFECTION 7 0.0013
290 POLYNEUROPATHY 15 0.0013
291 IMMUNOSUPPRESSION 11 0.0012
292 DERMATITIS BULLOUS 9 0.0012
293 LYMPHADENITIS 3 0.0012
294 NEUROLOGICAL SYMPTOM 7 0.0012
295 DENTAL OPERATION 3 0.0012
296 ACUTE PSYCHOSIS 3 0.0012
297 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 6 0.0012
298 DERMATITIS EXFOLIATIVE 6 0.0012
299 METASTASES TO PERITONEUM 3 0.0012
300 AGRANULOCYTOSIS 22 0.0012
301 DYSLIPIDAEMIA 6 0.0012
302 LUNG NEOPLASM 5 0.0012
303 HEPATOSPLENOMEGALY 3 0.0012
304 LEUKOCYTOSIS 21 0.0012
305 AMYLOIDOSIS 2 0.0012
306 HAEMATOTOXICITY 11 0.0012
307 BASAL CELL CARCINOMA 18 0.0012
308 BONE CANCER 5 0.0011
309 JAUNDICE CHOLESTATIC 4 0.0011
310 SEPTIC SHOCK 49 0.0011
311 BONE LESION 4 0.0011
312 COVID-19 PNEUMONIA 13 0.0011
313 BLOOD PHOSPHORUS INCREASED 3 0.0011
314 HAEMORRHAGE INTRACRANIAL 16 0.0011
315 CHRONIC SINUSITIS 4 0.0011
316 TENDERNESS 11 0.0011
317 HYPOPROTEINAEMIA 2 0.0011
318 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
319 LYMPHOMA 16 0.0010
320 GUILLAIN-BARRE SYNDROME 5 0.0010
321 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
322 LYMPHOPROLIFERATIVE DISORDER 3 0.0010
323 STRIDOR 3 0.0010
324 HYPERAEMIA 2 0.0010
325 INFUSION SITE REACTION 3 0.0010
326 OESOPHAGEAL CANDIDIASIS 4 0.0010
327 TYPE 1 DIABETES MELLITUS 6 0.0010
328 DEVICE RELATED SEPSIS 2 0.0010
329 PULMONARY TOXICITY 7 0.0010
330 INCORRECT PRODUCT STORAGE 13 0.0010
331 EAR HAEMORRHAGE 2 0.0010
332 BREAST DISORDER 2 0.0010
333 BODY TEMPERATURE INCREASED 20 0.0010
334 NEPHROPATHY TOXIC 11 0.0010
335 LEUKOPENIA 49 0.0010
336 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
337 RECTAL CANCER 3 0.0010
338 ARTHRITIS BACTERIAL 4 0.0010
339 DIVERTICULAR PERFORATION 2 0.0010
340 HYPERPARATHYROIDISM 2 0.0010
341 RASH PUSTULAR 7 0.0010
342 LEUKAEMIA 9 0.0010
343 BLINDNESS TRANSIENT 7 0.0009
344 TRANSAMINASES INCREASED 21 0.0009
345 PNEUMONITIS 25 0.0009
346 HYPERTHERMIA 7 0.0009
347 CLOSTRIDIUM TEST POSITIVE 2 0.0009
348 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
349 LYME DISEASE 3 0.0009
350 MENINGITIS 6 0.0009
351 BACTERIAL TEST POSITIVE 2 0.0009
352 ADENOCARCINOMA 2 0.0009
353 NEOPLASM PROGRESSION 31 0.0009
354 LARGE INTESTINAL HAEMORRHAGE 2 0.0009
355 FEAR OF DEATH 2 0.0009
356 NEOPLASM RECURRENCE 3 0.0009
357 CARDIOMYOPATHY 13 0.0009
358 INTENTIONAL PRODUCT USE ISSUE 77 0.0009
359 INFECTION 126 0.0009
360 HERPES VIRUS INFECTION 5 0.0009
361 APHTHOUS STOMATITIS 2 0.0009
362 ANAEMIA 164 0.0009
363 EMBOLIC STROKE 3 0.0009
364 SUDDEN DEATH 9 0.0008
365 CYTOKINE RELEASE SYNDROME 17 0.0008
366 TREATMENT FAILURE 70 0.0008
367 COLORECTAL CANCER METASTATIC 2 0.0008
368 PNEUMONIA 272 0.0008
369 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
370 CARDIAC DISORDER 78 0.0008
371 HEPATITIS CHOLESTATIC 5 0.0008
372 GANGRENE 5 0.0008
373 HEMIPARESIS 14 0.0008
374 THROMBOCYTOSIS 3 0.0008
375 BREATH SOUNDS ABNORMAL 4 0.0008
376 MALIGNANT NEOPLASM PROGRESSION 83 0.0008
377 STAPHYLOCOCCAL SEPSIS 4 0.0008
378 CARDIAC MURMUR 7 0.0008
379 ABDOMINAL TENDERNESS 4 0.0008
380 BACTERIAL INFECTION 15 0.0008
381 SEPSIS 89 0.0008
382 PROTEIN TOTAL DECREASED 3 0.0008
383 HEPATIC NECROSIS 3 0.0008
384 ERYSIPELAS 4 0.0008
385 LYMPHOCYTE COUNT DECREASED 14 0.0008
386 PURPURA 7 0.0008
387 DERMATOMYOSITIS 2 0.0008
388 EXCORIATION 2 0.0008
389 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
390 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20 0.0008
391 CARDIOPULMONARY FAILURE 3 0.0008
392 ORAL INFECTION 3 0.0008
393 CARDIAC FAILURE CONGESTIVE 61 0.0008
394 SKIN PAPILLOMA 3 0.0007
395 BLOOD SODIUM INCREASED 2 0.0007
396 CHEILITIS 4 0.0007
397 ATELECTASIS 7 0.0007
398 ACCIDENTAL EXPOSURE 3 0.0007
399 RASH MACULO-PAPULAR 16 0.0007
400 LUNG CONSOLIDATION 2 0.0007
401 NIGHT SWEATS 23 0.0007
402 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
403 HOSPICE CARE 7 0.0007
404 BUNDLE BRANCH BLOCK LEFT 3 0.0007
405 PREMATURE LABOUR 4 0.0007
406 FEBRILE BONE MARROW APLASIA 3 0.0007
407 AORTIC VALVE INCOMPETENCE 3 0.0007
408 HAEMATOLOGICAL MALIGNANCY 2 0.0007
409 PYREXIA 243 0.0007
410 GRANULOCYTOPENIA 4 0.0007
411 HYPERTONIA 4 0.0007
412 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
413 PLEURAL EFFUSION 42 0.0007
414 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
415 NEUROTOXICITY 12 0.0007
416 PARONYCHIA 3 0.0007
417 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
418 BACTERAEMIA 8 0.0007
419 RHINITIS ALLERGIC 3 0.0007
420 MALIGNANT MELANOMA 9 0.0007
421 BLOOD CULTURE POSITIVE 2 0.0007
422 HERPES ZOSTER 38 0.0007
423 URINE ABNORMALITY 3 0.0007
424 EMBOLISM VENOUS 2 0.0007
425 ISCHAEMIA 3 0.0007
426 INTRACARDIAC THROMBUS 2 0.0007
427 UROSEPSIS 6 0.0006
428 CHILLS 76 0.0006
429 THERAPY PARTIAL RESPONDER 10 0.0006
430 SARCOIDOSIS 3 0.0006
431 BRONCHOSPASM 9 0.0006
432 HEPATOTOXICITY 14 0.0006
433 NON-SMALL CELL LUNG CANCER 3 0.0006
434 ENTERITIS 4 0.0006
435 LIVER ABSCESS 2 0.0006
436 ORAL CANDIDIASIS 8 0.0006
437 SPINAL COMPRESSION FRACTURE 5 0.0006
438 COLON CANCER 9 0.0006
439 IMMUNODEFICIENCY 9 0.0006
440 ACUTE CORONARY SYNDROME 5 0.0006
441 CARDIAC FAILURE ACUTE 4 0.0006
442 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
443 CANDIDA INFECTION 10 0.0006
444 BLOOD PRESSURE DECREASED 39 0.0006
445 NEUTROPHIL COUNT INCREASED 6 0.0006
446 NEPHROTIC SYNDROME 4 0.0006
447 ECCHYMOSIS 4 0.0006
448 CEREBRAL ISCHAEMIA 3 0.0006
449 ONYCHOCLASIS 4 0.0006
450 SKIN NECROSIS 3 0.0006
451 HYPERGLYCAEMIA 21 0.0006
452 ACUTE RESPIRATORY FAILURE 11 0.0006
453 HAEMORRHAGIC DIATHESIS 2 0.0006
454 HAEMATOCRIT DECREASED 11 0.0006
455 OESOPHAGITIS 6 0.0005
456 GASTROENTERITIS 8 0.0005
457 ORAL DISORDER 4 0.0005
458 ACUTE MYOCARDIAL INFARCTION 16 0.0005
459 HYPOXIA 19 0.0005
460 NECROSIS 3 0.0005
461 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
462 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
463 GENERALISED ERYTHEMA 3 0.0005
464 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
465 MULTI-ORGAN FAILURE 9 0.0005
466 PNEUMONIA ASPIRATION 13 0.0005
467 MUSCULOSKELETAL CHEST PAIN 8 0.0005
468 RALES 3 0.0005
469 METABOLIC DISORDER 3 0.0005
470 ATRIAL FIBRILLATION 50 0.0005
471 SKIN CANCER 11 0.0005
472 ENERGY INCREASED 3 0.0005
473 CHOLECYSTITIS 6 0.0005
474 MYOCLONUS 6 0.0005
475 AZOTAEMIA 2 0.0005
476 HEARING IMPAIRED 3 0.0005
477 CANDIDIASIS 2 0.0005
478 WHITE BLOOD CELL COUNT DECREASED 54 0.0005
479 MUCOSAL INFLAMMATION 13 0.0005
480 CYSTITIS HAEMORRHAGIC 2 0.0005
481 DECUBITUS ULCER 4 0.0005
482 DRUG ADMINISTRATION ERROR 15 0.0005
483 DEMYELINATION 2 0.0005
484 EXTRAVASATION 2 0.0005
485 HYPERCALCAEMIA 6 0.0005
486 OLIGURIA 3 0.0005
487 EMBOLISM 4 0.0005
488 HEMIPLEGIA 4 0.0005
489 OXYGEN SATURATION DECREASED 27 0.0005
490 FUNGAL INFECTION 16 0.0005
491 URINARY RETENTION 16 0.0005
492 PETECHIAE 5 0.0005
493 FOLLICULITIS 5 0.0005
494 PROTEINURIA 9 0.0005
495 HYPERPYREXIA 2 0.0005
496 CARDIAC FAILURE CHRONIC 2 0.0005
497 PLATELET COUNT DECREASED 50 0.0005
498 C-REACTIVE PROTEIN INCREASED 17 0.0005
499 DRUG RESISTANCE 12 0.0005
500 GENERAL PHYSICAL HEALTH DETERIORATION 54 0.0005
501 ANOREXIA 6 0.0005
502 APHASIA 14 0.0005
503 PYELONEPHRITIS 4 0.0005
504 PLATELET COUNT INCREASED 6 0.0005
505 ASPIRATION 5 0.0005
506 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
507 HYPERTENSIVE CRISIS 5 0.0004
508 SKIN MASS 3 0.0004
509 CARDIOTOXICITY 4 0.0004
510 FACIAL PAIN 4 0.0004
511 HAEMOGLOBIN DECREASED 46 0.0004
512 CEREBRAL HAEMORRHAGE 16 0.0004
513 MITRAL VALVE INCOMPETENCE 5 0.0004
514 TACHYPNOEA 6 0.0004
515 MUSCULAR WEAKNESS 50 0.0004
516 RESPIRATORY FAILURE 32 0.0004
517 HAEMOGLOBIN INCREASED 2 0.0004
518 SKIN LESION 12 0.0004
519 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
520 NEOPLASM 5 0.0004
521 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
522 LOCALISED OEDEMA 2 0.0004
523 HYPERTRANSAMINASAEMIA 3 0.0004
524 SKIN REACTION 6 0.0004
525 STAPHYLOCOCCAL INFECTION 14 0.0004
526 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
527 HYPOKINESIA 6 0.0004
528 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
529 HYDRONEPHROSIS 3 0.0004
530 RENAL FAILURE ACUTE 17 0.0004
531 BLOOD COUNT ABNORMAL 6 0.0004
532 TROPONIN INCREASED 3 0.0004
533 BOWEL MOVEMENT IRREGULARITY 3 0.0004
534 VIRAL INFECTION 13 0.0004
535 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
536 CONGENITAL ANOMALY 3 0.0004
537 OSTEOMYELITIS 7 0.0004
538 FAILURE TO THRIVE 2 0.0004
539 APLASTIC ANAEMIA 2 0.0004
540 TACHYCARDIA 34 0.0004
541 TRANSFUSION 4 0.0004
542 FURUNCLE 3 0.0004
543 THERAPY NON-RESPONDER 17 0.0004
544 EAR INFECTION 10 0.0004
545 ALANINE AMINOTRANSFERASE INCREASED 23 0.0004
546 FOOD POISONING 2 0.0004
547 BLOOD SODIUM DECREASED 7 0.0004
548 ANAL ABSCESS 2 0.0004
549 GINGIVITIS 2 0.0004
550 RENAL IMPAIRMENT 31 0.0004
551 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
552 PULMONARY FIBROSIS 7 0.0004
553 ESCHERICHIA INFECTION 3 0.0004
554 CHOLESTASIS 7 0.0004
555 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
556 GLAUCOMA 7 0.0004
557 HYPERSENSITIVITY 67 0.0004
558 BLOOD UREA INCREASED 6 0.0004
559 DEMENTIA 10 0.0004
560 DISEASE RECURRENCE 17 0.0004
561 SKIN PLAQUE 3 0.0004
562 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
563 CHOLECYSTITIS ACUTE 2 0.0004
564 HEPATOCELLULAR INJURY 5 0.0004
565 CIRCULATORY COLLAPSE 6 0.0004
566 HYPOPHAGIA 9 0.0004
567 HEPATITIS 9 0.0004
568 HYPERHIDROSIS 45 0.0003
569 SUBDURAL HAEMATOMA 5 0.0003
570 BLOOD URIC ACID INCREASED 2 0.0003
571 LOCAL SWELLING 6 0.0003
572 NAIL DISORDER 3 0.0003
573 EOSINOPHILIA 6 0.0003
574 HYPOVOLAEMIA 2 0.0003
575 SPINAL OSTEOARTHRITIS 3 0.0003
576 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
577 DRUG ERUPTION 6 0.0003
578 BRONCHITIS 25 0.0003
579 CATARACT OPERATION 2 0.0003
580 GALLBLADDER DISORDER 6 0.0003
581 GASTROINTESTINAL INFECTION 3 0.0003
582 MOUTH ULCERATION 7 0.0003
583 BONE DISORDER 6 0.0003
584 URINARY TRACT INFECTION 56 0.0003
585 DISORIENTATION 13 0.0003
586 NO THERAPEUTIC RESPONSE 4 0.0003
587 INCREASED TENDENCY TO BRUISE 3 0.0003
588 ANAPHYLACTIC REACTION 18 0.0003
589 SMALL INTESTINAL OBSTRUCTION 4 0.0003
590 GRAND MAL CONVULSION 3 0.0003
591 LARYNGEAL OEDEMA 2 0.0003
592 HYPOTENSION 65 0.0003
593 GENERALISED OEDEMA 4 0.0003
594 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
595 ERYTHEMA MULTIFORME 3 0.0003
596 FLANK PAIN 3 0.0003
597 DERMATITIS ALLERGIC 4 0.0003
598 BRAIN OEDEMA 4 0.0003
599 RED BLOOD CELL COUNT DECREASED 9 0.0003
600 PULMONARY OEDEMA 14 0.0003
601 ANGINA UNSTABLE 2 0.0003
602 OFF LABEL USE 269 0.0003
603 HEPATOMEGALY 3 0.0003
604 PRODUCT USE IN UNAPPROVED INDICATION 75 0.0003
605 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
606 BLADDER DISORDER 3 0.0003
607 HYPOTONIA 3 0.0003
608 BREAST MASS 2 0.0003
609 CELLULITIS 15 0.0003
610 EMPHYSEMA 3 0.0003
611 FACE OEDEMA 5 0.0003
612 HYPOTHERMIA 3 0.0003
613 DYSPHAGIA 28 0.0003
614 NEUTROPHIL COUNT DECREASED 12 0.0003
615 PALLOR 8 0.0003
616 DRUG TOXICITY 4 0.0003
617 GINGIVAL BLEEDING 4 0.0003
618 HAEMATURIA 10 0.0003
619 OSTEOPOROSIS 12 0.0003
620 BLOOD CREATININE INCREASED 19 0.0003
621 HYPERBILIRUBINAEMIA 3 0.0003
622 ORTHOSTATIC HYPOTENSION 5 0.0003
623 COORDINATION ABNORMAL 4 0.0003
624 EXTRASYSTOLES 2 0.0003
625 INCONTINENCE 3 0.0003
626 COLD SWEAT 5 0.0003
627 RENAL PAIN 3 0.0003
628 BRADYCARDIA 15 0.0003
629 STOMATITIS 17 0.0003
630 METASTASIS 2 0.0003
631 ANGINA PECTORIS 8 0.0003
632 GOUT 5 0.0003
633 MYELOSUPPRESSION 10 0.0003
634 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
635 MYALGIA 47 0.0003
636 WOUND INFECTION 3 0.0003
637 MAJOR DEPRESSION 2 0.0003
638 TOXICITY TO VARIOUS AGENTS 46 0.0003
639 TREMOR 45 0.0003
640 HAEMATOMA 7 0.0003
641 HAEMORRHAGE 28 0.0003
642 BLOOD CALCIUM DECREASED 3 0.0003
643 EYE INFECTION 3 0.0003
644 DYSARTHRIA 10 0.0003
645 REBOUND EFFECT 3 0.0003
646 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
647 HAEMODYNAMIC INSTABILITY 2 0.0003
648 EPILEPSY 8 0.0003
649 DEEP VEIN THROMBOSIS 17 0.0003
650 BLOOD BILIRUBIN INCREASED 7 0.0003
651 DELUSION 4 0.0003
652 HYPOALBUMINAEMIA 2 0.0003
653 ORAL HERPES 5 0.0003
654 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
655 CYANOSIS 4 0.0003
656 SINUSITIS 26 0.0003
657 RESPIRATORY DISTRESS 7 0.0003
658 ATAXIA 3 0.0003
659 PNEUMOTHORAX 4 0.0003
660 BLOOD ALBUMIN DECREASED 2 0.0003
661 UPPER LIMB FRACTURE 5 0.0003
662 ATRIAL FLUTTER 2 0.0003
663 HYPONATRAEMIA 14 0.0002
664 HEPATITIS C 3 0.0002
665 INTERSTITIAL LUNG DISEASE 12 0.0002
666 NEURALGIA 6 0.0002
667 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
668 HAIR DISORDER 2 0.0002
669 VENTRICULAR TACHYCARDIA 4 0.0002
670 PULMONARY EMBOLISM 23 0.0002
671 VISUAL ACUITY REDUCED 8 0.0002
672 EOSINOPHIL COUNT INCREASED 2 0.0002
673 NEOPLASM MALIGNANT 16 0.0002
674 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 17 0.0002
675 HAEMODIALYSIS 2 0.0002
676 HALLUCINATION, VISUAL 5 0.0002
677 CARDIOVASCULAR DISORDER 6 0.0002
678 HEPATIC CYTOLYSIS 3 0.0002
679 FACIAL PARALYSIS 2 0.0002
680 RESPIRATORY DISORDER 7 0.0002
681 RENAL FAILURE 31 0.0002
682 INFLAMMATION 12 0.0002
683 THERAPEUTIC RESPONSE DECREASED 14 0.0002
684 NODULE 3 0.0002
685 SYNCOPE 23 0.0002
686 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
687 BEDRIDDEN 3 0.0002
688 CARDIAC FAILURE 18 0.0002
689 ORAL PAIN 5 0.0002
690 COVID-19 39 0.0002
691 SYNOVITIS 4 0.0002
692 GASTROENTERITIS VIRAL 4 0.0002
693 CHEST PAIN 41 0.0002
694 DYSPNOEA 125 0.0002
695 NEUROPATHY PERIPHERAL 21 0.0002
696 ACUTE HEPATIC FAILURE 3 0.0002
697 END STAGE RENAL DISEASE 4 0.0002
698 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
699 CATARACT 13 0.0002
700 NEPHROLITHIASIS 10 0.0002
701 MUSCLE TWITCHING 5 0.0002
702 PERICARDIAL EFFUSION 5 0.0002
703 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
704 MEDICATION ERROR 12 0.0002
705 FEELING COLD 6 0.0002
706 MASS 3 0.0002
707 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
708 APPENDICITIS 2 0.0002
709 COUGH 60 0.0002
710 DIALYSIS 3 0.0002
711 ARRHYTHMIA 10 0.0002
712 CONFUSIONAL STATE 34 0.0002
713 MUSCULOSKELETAL DISORDER 4 0.0002
714 FEELING JITTERY 4 0.0002
715 SKIN DISORDER 7 0.0002
716 EYE INFLAMMATION 2 0.0002
717 WEIGHT DECREASED 58 0.0002
718 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
719 ASTHENIA 78 0.0002
720 LIVER FUNCTION TEST ABNORMAL 6 0.0002
721 APATHY 3 0.0002
722 PALPITATIONS 24 0.0002
723 INFLAMMATORY BOWEL DISEASE 2 0.0002
724 AGITATION 15 0.0002
725 LUNG DISORDER 10 0.0002
726 KIDNEY INFECTION 4 0.0002
727 ENCEPHALOPATHY 5 0.0002
728 ACUTE KIDNEY INJURY 31 0.0002
729 URINARY INCONTINENCE 6 0.0002
730 SPINAL FRACTURE 4 0.0002
731 SEIZURE 23 0.0002
732 OSTEOPENIA 3 0.0002
733 OEDEMA PERIPHERAL 24 0.0002
734 EYELID PTOSIS 2 0.0002
735 DRUG DISPENSING ERROR 3 0.0002
736 COGNITIVE DISORDER 9 0.0002
737 NERVOUS SYSTEM DISORDER 6 0.0002
738 PULMONARY HYPERTENSION 4 0.0002
739 BONE PAIN 11 0.0002
740 CONTUSION 18 0.0002
741 DRUG INTOLERANCE 18 0.0002
742 HYPOACUSIS 8 0.0002
743 COLITIS 7 0.0002
744 OSTEONECROSIS 6 0.0002
745 MELAENA 4 0.0002
746 VOMITING 85 0.0002
747 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
748 DIVERTICULITIS 5 0.0002
749 COAGULOPATHY 3 0.0002
750 MENTAL STATUS CHANGES 5 0.0002
751 STEVENS-JOHNSON SYNDROME 4 0.0002
752 HYPERTENSION 38 0.0002
753 INTESTINAL PERFORATION 2 0.0002
754 CHROMATURIA 4 0.0002
755 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
756 DERMATITIS CONTACT 2 0.0002
757 EPISTAXIS 13 0.0002
758 ASCITES 5 0.0002
759 WHEEZING 10 0.0002
760 GASTROINTESTINAL HAEMORRHAGE 14 0.0002
761 MACULAR DEGENERATION 2 0.0002
762 CEREBROVASCULAR ACCIDENT 28 0.0002
763 DRUG EFFECT INCOMPLETE 6 0.0002
764 CORONARY ARTERY DISEASE 5 0.0002
765 ADRENAL INSUFFICIENCY 2 0.0002
766 ILL-DEFINED DISORDER 10 0.0002
767 RESTLESSNESS 6 0.0002
768 DYSURIA 6 0.0002
769 CARDIOMEGALY 2 0.0002
770 INJECTION SITE EXTRAVASATION 2 0.0002
771 CONJUNCTIVITIS 3 0.0002
772 OSTEONECROSIS OF JAW 4 0.0002
773 DRUG-INDUCED LIVER INJURY 5 0.0002
774 GASTRIC ULCER 3 0.0002
775 DEHYDRATION 21 0.0002
776 SLEEP APNOEA SYNDROME 3 0.0002
777 CHEST DISCOMFORT 16 0.0002
778 DRUG INEFFECTIVE 204 0.0002
779 SKIN ULCER 4 0.0002
780 HIATUS HERNIA 2 0.0002
781 RASH GENERALISED 4 0.0002
782 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
783 HAEMORRHOIDS 3 0.0002
784 SPEECH DISORDER 8 0.0002
785 IMMUNE SYSTEM DISORDER 2 0.0002
786 DISABILITY 3 0.0002
787 SINUS DISORDER 3 0.0002
788 CONSTIPATION 33 0.0002
789 BACK PAIN 35 0.0002
790 FULL BLOOD COUNT DECREASED 3 0.0001
791 JAUNDICE 4 0.0001
792 TYPE 2 DIABETES MELLITUS 5 0.0001
793 PRODUCT ADMINISTRATION ERROR 3 0.0001
794 VERTIGO 9 0.0001
795 FEELING HOT 9 0.0001
796 HEPATIC ENZYME INCREASED 10 0.0001
797 RASH ERYTHEMATOUS 7 0.0001
798 LUNG NEOPLASM MALIGNANT 6 0.0001
799 ABDOMINAL PAIN UPPER 30 0.0001
800 CARDIAC ARREST 12 0.0001
801 DERMATITIS 3 0.0001
802 HYPERKALAEMIA 5 0.0001
803 BLOOD TEST ABNORMAL 2 0.0001
804 BLINDNESS UNILATERAL 2 0.0001
805 NAUSEA 112 0.0001
806 EATING DISORDER 3 0.0001
807 LIVER FUNCTION TEST INCREASED 3 0.0001
808 CARDIOGENIC SHOCK 2 0.0001
809 IMPAIRED QUALITY OF LIFE 2 0.0001
810 AMNESIA 9 0.0001
811 MENTAL DISORDER 6 0.0001
812 FLUID OVERLOAD 2 0.0001
813 PRODUCT STORAGE ERROR 12 0.0001
814 RASH 59 0.0001
815 LIVER DISORDER 6 0.0001
816 DEATH 116 0.0001
817 RASH PAPULAR 3 0.0001
818 PARAESTHESIA 21 0.0001
819 HEART RATE IRREGULAR 3 0.0001
820 DYSPNOEA EXERTIONAL 5 0.0001
821 HALLUCINATION 10 0.0001
822 PANCREATITIS 7 0.0001
823 MALAISE 58 0.0001
824 CONDITION AGGRAVATED 40 0.0001
825 DIABETES MELLITUS 10 0.0001
826 FATIGUE 102 0.0001
827 DIARRHOEA 84 0.0001
828 RASH PRURITIC 7 0.0001
829 PLASMA CELL MYELOMA 5 0.0001
830 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
831 HEAD INJURY 4 0.0001
832 MYOCARDIAL INFARCTION 22 0.0001
833 METABOLIC ACIDOSIS 4 0.0001
834 DIABETIC KETOACIDOSIS 3 0.0001
835 BLISTER 7 0.0001
836 PROSTATE CANCER 10 0.0001
837 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
838 PRESYNCOPE 3 0.0001
839 CHOLELITHIASIS 4 0.0001
840 IMPAIRED HEALING 4 0.0001
841 EYE IRRITATION 7 0.0001
842 PRODUCT USE ISSUE 22 0.0001
843 THERAPY CESSATION 6 0.0001
844 ANAPHYLACTIC SHOCK 3 0.0001
845 DECREASED APPETITE 27 0.0001
846 DEAFNESS 3 0.0001
847 METASTASES TO LIVER 2 0.0001
848 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
849 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
850 ISCHAEMIC STROKE 2 0.0001
851 THROAT TIGHTNESS 3 0.0001
852 MUSCLE SPASMS 20 0.0001
853 FLUSHING 11 0.0001
854 EYE SWELLING 4 0.0001
855 RENAL DISORDER 5 0.0001
856 HEPATIC CIRRHOSIS 2 0.0001
857 INTESTINAL OBSTRUCTION 4 0.0001
858 CHRONIC KIDNEY DISEASE 8 0.0001
859 CONVULSION 6 0.0001
860 LETHARGY 6 0.0001
861 DYSTONIA 2 0.0001
862 DIZZINESS 51 0.0001
863 ARTHRITIS 8 0.0001
864 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
865 BLOOD POTASSIUM DECREASED 3 0.0001
866 PREMATURE BABY 3 0.0001
867 HEPATIC FAILURE 3 0.0001
868 THERAPY INTERRUPTED 7 0.0001
869 INFLUENZA LIKE ILLNESS 8 0.0001
870 DEPRESSION 22 0.0001
871 POLLAKIURIA 4 0.0001
872 ABDOMINAL DISTENSION 10 0.0001
873 NERVOUSNESS 5 0.0001
874 CARDIO-RESPIRATORY ARREST 4 0.0001
875 ABDOMINAL PAIN 22 0.0001
876 OSTEOARTHRITIS 4 0.0001
877 CYSTITIS 3 0.0001
878 HYPOTHYROIDISM 3 0.0001
879 ARTHRALGIA 39 0.0001
880 LOSS OF CONSCIOUSNESS 12 0.0001
881 RECTAL HAEMORRHAGE 4 0.0001
882 BALANCE DISORDER 8 0.0001
883 NASOPHARYNGITIS 17 0.0001
884 ALOPECIA 18 0.0001
885 PRURITUS 35 0.0001
886 ANGIOEDEMA 4 0.0001
887 FALL 30 0.0001
888 ARTHROPATHY 5 0.0001
889 VISION BLURRED 12 0.0001
890 ADVERSE EVENT 8 0.0001
891 DELIRIUM 3 0.0001
892 COMA 4 0.0001
893 PRODUCTIVE COUGH 4 0.0001
894 HEPATIC CANCER 2 0.0001
895 INSOMNIA 22 0.0001
896 ACCIDENTAL OVERDOSE 3 0.0001
897 CEREBRAL INFARCTION 2 0.0001
898 LIVER INJURY 2 0.0001
899 VISUAL IMPAIRMENT 10 0.0001
900 HYPOAESTHESIA 12 0.0001
901 DRY EYE 4 0.0001
902 PERIPHERAL SWELLING 12 0.0001
903 ERYTHEMA 16 0.0001
904 URTICARIA 13 0.0001
905 RHINORRHOEA 5 0.0001
906 SWELLING FACE 5 0.0001
907 GASTRITIS 2 0.0001
908 FEAR 2 0.0001
909 DRUG EFFECT DECREASED 4 0.0001
910 DISTURBANCE IN ATTENTION 4 0.0001
911 DYSKINESIA 3 0.0001
912 OEDEMA 4 0.0001
913 BLINDNESS 3 0.0001
914 TREATMENT NONCOMPLIANCE 4 0.0001
915 HAEMATOCHEZIA 4 0.0001
916 INFLUENZA 8 0.0001
917 HAEMOPTYSIS 2 0.0001
918 HOSPITALISATION 11 0.0001
919 NECK PAIN 4 0.0001
920 DYSPEPSIA 7 0.0001
921 ANXIETY 20 0.0001
922 HEADACHE 44 0.0001
923 HYPERSOMNIA 2 0.0001
924 VAGINAL HAEMORRHAGE 3 0.0001
925 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
926 PAIN IN EXTREMITY 20 0.0001
927 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
928 ADVERSE DRUG REACTION 6 0.0001
929 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
930 TINNITUS 3 0.0001
931 SKIN DISCOLOURATION 3 0.0001
932 HYPOKALAEMIA 3 0.0001
933 LIMB DISCOMFORT 2 0.0001
934 FEMUR FRACTURE 2 0.0001
935 RENAL CANCER 3 0.0001
936 GAIT DISTURBANCE 12 0.0001
937 HIP FRACTURE 2 0.0001
938 PAIN 37 0.0001
939 EXPIRED PRODUCT ADMINISTERED 2 0.0001
940 LIP SWELLING 2 0.0001
941 AGGRESSION 3 0.0001
942 ABDOMINAL DISCOMFORT 10 0.0001
943 SOMNOLENCE 12 0.0001
944 BLOOD PRESSURE INCREASED 9 0.0001
945 BLOOD GLUCOSE INCREASED 11 0.0001
946 INJECTION SITE REACTION 4 0.0001
947 MUSCULOSKELETAL PAIN 3 0.0001
948 HEART RATE DECREASED 2 0.0001
949 INJURY 4 0.0001
950 DRUG INTERACTION 9 0.0001
951 SKIN BURNING SENSATION 4 0.0001
952 GASTROINTESTINAL DISORDER 5 0.0001
953 UNDERDOSE 4 0.0001
954 FEELING ABNORMAL 13 0.0001
955 OROPHARYNGEAL PAIN 5 0.0001
956 HOT FLUSH 4 0.0001
957 UNEVALUABLE EVENT 4 0.0001
958 INCORRECT DOSE ADMINISTERED 12 0.0001
959 MEMORY IMPAIRMENT 7 0.0001
960 BLADDER CANCER 3 0.0001
961 SUICIDE ATTEMPT 3 0.0000
962 DRY MOUTH 4 0.0000
963 DISCOMFORT 3 0.0000
964 DRUG DOSE OMISSION 8 0.0000
965 PRODUCT DOSE OMISSION 3 0.0000
966 DRY SKIN 6 0.0000
967 ASTHMA 5 0.0000
968 NO ADVERSE EVENT 8 0.0000
969 BREAST CANCER 4 0.0000
970 BLOOD CHOLESTEROL INCREASED 2 0.0000
971 EMOTIONAL DISTRESS 5 0.0000
972 HYPOGLYCAEMIA 2 0.0000
973 FLUID RETENTION 2 0.0000
974 WEIGHT INCREASED 8 0.0000
975 DYSPHONIA 2 0.0000
976 JOINT SWELLING 4 0.0000
977 SUICIDAL IDEATION 3 0.0000
978 SWELLING 3 0.0000
979 PSORIASIS 4 0.0000
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
981 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
982 PRODUCT DOSE OMISSION ISSUE 8 0.0000
983 ACNE 2 0.0000
984 HEART RATE INCREASED 2 0.0000
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
986 OVERDOSE 3 0.0000